The Caveolin-1 Expression in Canine Mammary Cancer
World Small Animal Veterinary Association World Congress Proceedings, 2007
Debora Zuccari; Arieli Gavioli; Juliana Carmona; Luana Pivaro; Ana Carolina Terzian; Rodrigo Castro; Cibelli Frade; Eloiza Tajara
Famerp, SP, Brazil

Caveolin-1, an essential structural component of caveolae, functions as a negative regulator for signal transduction and has been suggested to be a candidate tumor suppressor gene. Lack of caveolin-1 expression has been implicated in tumorigenesis in many cancers and its importance in mammary tumoral cells has been confirmed. However, the exact functional role of caveolin-1 remains controversial. Based on an immunohistochemical study, the expression levels of caveolin-1 in 73 female dogs with mammary neoplasia were investigated by Real-Time PCR, and correlations with clinicopathologic variables were evaluated statistically. PCR amplifications were performed using a 7500 Fast Real-Time PCR System. The gene expression stability over different samples was analyzed using the geNorm software. There was less expression of caveolin-1 in mammary tumors compared with normal mammary tissue in all group. Multivariate analyses indicated that clinical stage, histologic grade, and outcome were independent prognostic factors. The presence of clinical symptoms and the down-regulation of caveolin-1 were identified as negative prognostic predictors in the univariate analysis (P < .05). Reduced expression of caveolin-1 may indicate a poor prognosis and the current results suggest that caveolin-1 may function as a tumor suppressor gene in mammary cancer.

Financial Support: FAPESP

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Debora Zuccari

MAIN : Abstracts - Poster : Caveolin-1 Expression
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616


  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357